![]() |
|
|
Manuscript received 24 July 1998. Initial reviews completed 10 September 1998. Revision accepted 23 October 1998.
Department of Medicine, University of Florida College of Medicine and the VA Medical Center, Gainesville, FL
To examine the modulation of arterial thrombosis by vitamins C and E, Sprague-Dawley rats were fed nonpurified diet, or diet mixed with vitamin C [100 mg/(kg body weight·d)], vitamin E [100 mg/(kg·d)] or both vitamins C and E [each 100 mg/(kg·d)], for a period of 9-19 d (mean 15 d). An occlusive aortic thrombus was created by application of a Whatman filter soaked in 1 mol/L FeCl3. Both vitamins C and E and their combination decreased platelet aggregation and delayed time to occlusive thrombus formation (P < 0.05 vs. control). Vitamins C and E decreased arterial superoxide generation (P < 0.05 vs. control). Interestingly, vitamin E also increased endogenous superoxide dismutase activity (SOD) and protein expression in aortic tissues (P < 0.05 vs. control). The combination of vitamins C and E was not superior to each vitamin alone with regard to effect on time to thrombus formation, but it was more potent with regard to platelet inhibition. The increase in endogenous antioxidant activity by vitamin E is an intriguing observation. This study shows that the antioxidant vitamins C and E have important effects on platelet aggregation, SOD activity, superoxide generation and thrombus formation.
Key words: platelet aggregation, thrombosis, superoxide dismutase, vitamin C, vitamin E, rats.
The Journal of Nutrition Vol. 129 No. 1 January 1999,
pp. 109-112
Copyright ©1999 by the American Society for Nutritional Sciences
This article has been cited by other articles:
![]() |
H. D. Sesso, J. E. Buring, W. G. Christen, T. Kurth, C. Belanger, J. MacFadyen, V. Bubes, J. E. Manson, R. J. Glynn, and J. M. Gaziano Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial JAMA, November 12, 2008; 300(18): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Marsh and J. S. Coombes Vitamin E and a-Lipoic Acid Supplementation Increase Bleeding Tendency via an Intrinsic Coagulation Pathway Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 169 - 173. [Abstract] [PDF] |
||||
![]() |
M. Liu, A. Wallmon, C. Olsson-Mortlock, R. Wallin, and T. Saldeen Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms Am. J. Clinical Nutrition, March 1, 2003; 77(3): 700 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, T. Saldeen, F. Romeo, and J. L. Mehta Different Isoforms of Tocopherols Enhance Nitric Oxide Synthase Phosphorylation and Inhibit Human Platelet Aggregation and Lipid Peroxidation: Implications in Therapy with Vitamin E Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 155 - 161. [Abstract] [PDF] |
||||
![]() |
J. S. Coombes, S. K. Powers, K. L. Hamilton, H. A. Demirel, R. A. Shanely, M. A. Zergeroglu, C. K. Sen, L. Packer, and L. L. Ji Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alpha -lipoic acid Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2149 - R2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Bavry, D. Li, D. S. Zander, M. I. Phillips, and J. L. Mehta Inhibition of Arterial Thrombogenesis by Quinapril but Not Losartan Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 121 - 127. [Abstract] [PDF] |
||||
![]() |
T. Saldeen, D. Li, and J. L. Mehta Differential effects of {alpha}- and {gamma}-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1208 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
Dayuan Li, T. Saldeen, F. Romeo, and J. L. Mehta Relative Effects of {alpha}- and {gamma}-Tocopherol on Low-Density Lipoprotein Oxidation and Superoxide Dismutase and Nitric Oxide Synthase Activity and Protein Expression in Rats Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 219 - 226. [Abstract] [PDF] |
||||